Literature DB >> 6145671

The role of neurotransmitters in the genesis of uremic encephalopathy.

S Biasioli, G D'Andrea, S Chiaramonte, A Fabris, M Feriani, C Ronco, D Borin, A Brendolan, G La Greca.   

Abstract

To classify the influence of neurotransmitters in the genesis of uremic encephalopathy we studied cerebrospinal fluid (CSF) and plasma (P) amino acid (AA) concentration, in patients undergoing various dialytic treatments (hemodialysis = HD, intermittent and continuous peritoneal dialysis = IPD and CAPD). HD causes a significant decrease in CSF/P ratios of branched chain AA (BCAA) and a significant increase in CSF Glycine/Valine ratio, suggesting an augmented brain uptake of Glycine at detriment of Valine. In IPD the general trend of Aromatic AA/BCAA ratio suggests a preferential transport of Aromatic AA through the blood brain barrier. The differences between IPD and HD are confirmed by data concerning metabolites of Serotonin and Dopamine: CSF concentrations of 5- Hydroxyindoleacetic acid and Homovanillic acid are low in HD but high in IPD. So, a reduced (in HD) and an increased (in IPD) activity of monoamine systems could be at the basis of some neurological disturbances appearing in uremia.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6145671

Source DB:  PubMed          Journal:  Int J Artif Organs        ISSN: 0391-3988            Impact factor:   1.595


  3 in total

1.  Reversible MRI and CT findings in uremic encephalopathy.

Authors:  J Okada; K Yoshikawa; H Matsuo; K Kanno; M Oouchi
Journal:  Neuroradiology       Date:  1991       Impact factor: 2.804

2.  Syndrome of uremic encephalopathy and bilateral basal ganglia lesions in non-diabetic hemodialysis patient: a case report.

Authors:  Wen-Yu Gong; Shan-Shan Li; Zong-Chao Yu; Hong-Wei Wu; Liang-Hong Yin; Li-Fan Mei; Fan-Na Liu
Journal:  BMC Nephrol       Date:  2018-12-19       Impact factor: 2.388

3.  Uremic encephalopathy with atypical magnetic resonance features on diffusion-weighted images.

Authors:  Eugene Kang; Se Jeong Jeon; See-Sung Choi
Journal:  Korean J Radiol       Date:  2012-10-12       Impact factor: 3.500

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.